Relative to preceding timepoints, at the time of tumor progression (Week 60 timepoint), activation markers and immune checkpoints were highly expressed in Treg cells, but relatively decreased in effector cells (CD4 and CD8). This evidence concerns the gene CD4 and neoplasm.